Tozaro
- Other products or services
- Other R&D services
Tozaro is developing a novel suite of affinity reagents to help transform the development and manufacture of viral vectors in cell and gene therapy. Operating at the intersection of chemistry, computational biology and cell and gene therapy, Tozaro’s smart polymers are improving on current analytical and purification processes to realize a future where advanced therapies are more accessible to all.
Tozaro is partnering with leading companies in the cell and gene therapy sector to introduce novel synthetic affinity reagents, aligned to critical applications. The Company is backed by leading life sciences investor groups, including Mercia, BGF and Calculus Capital.
Address
SharnbrookUnited Kingdom
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}